These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34974289)
1. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21. Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289 [TBL] [Abstract][Full Text] [Related]
2. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Li Y; Schwab C; Ryan S; Papaemmanuil E; Robinson HM; Jacobs P; Moorman AV; Dyer S; Borrow J; Griffiths M; Heerema NA; Carroll AJ; Talley P; Bown N; Telford N; Ross FM; Gaunt L; McNally RJQ; Young BD; Sinclair P; Rand V; Teixeira MR; Joseph O; Robinson B; Maddison M; Dastugue N; Vandenberghe P; Stephens PJ; Cheng J; Van Loo P; Stratton MR; Campbell PJ; Harrison CJ Nature; 2014 Apr; 508(7494):98-102. PubMed ID: 24670643 [TBL] [Abstract][Full Text] [Related]
3. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia. Harrison CJ; Schwab C Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400 [TBL] [Abstract][Full Text] [Related]
4. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21. Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796 [TBL] [Abstract][Full Text] [Related]
5. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21. Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493 [TBL] [Abstract][Full Text] [Related]
6. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease. Harrison CJ Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562 [TBL] [Abstract][Full Text] [Related]
7. Coexistence of iAMP21 and Gu J; Reynolds A; Fang L; DeGraffenreid C; Sterns K; Patel KP; Medeiros LJ; Lin P; Lu X Mol Cytogenet; 2016; 9():84. PubMed ID: 27895713 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review. Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468 [TBL] [Abstract][Full Text] [Related]
9. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia. Kim J; Lyu CJ; Shin S; Lee ST; Choi JR Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714 [TBL] [Abstract][Full Text] [Related]
10. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia. Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852 [TBL] [Abstract][Full Text] [Related]
11. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA; Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298 [TBL] [Abstract][Full Text] [Related]
12. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal? Tsuchiya KD; Davis B; Gardner RA Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092 [TBL] [Abstract][Full Text] [Related]
13. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686 [TBL] [Abstract][Full Text] [Related]
14. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221 [TBL] [Abstract][Full Text] [Related]
15. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group. Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717 [TBL] [Abstract][Full Text] [Related]
16. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle. Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia. Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088 [TBL] [Abstract][Full Text] [Related]
18. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Strefford JC; van Delft FW; Robinson HM; Worley H; Yiannikouris O; Selzer R; Richmond T; Hann I; Bellotti T; Raghavan M; Young BD; Saha V; Harrison CJ Proc Natl Acad Sci U S A; 2006 May; 103(21):8167-72. PubMed ID: 16702559 [TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial. Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA; Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866 [TBL] [Abstract][Full Text] [Related]
20. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]